NCT06391775 2025-12-26
Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy
Genmab
Phase 1/2 Terminated
Genmab
Zai Lab (Hong Kong), Ltd.
Jewish General Hospital
Peregrine Pharmaceuticals